132 related articles for article (PubMed ID: 33360684)
21. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
[TBL] [Abstract][Full Text] [Related]
22. Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J; Madsen P; Møller JM; Aardestrup I; Schmidt EB
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):137-41. PubMed ID: 20638827
[TBL] [Abstract][Full Text] [Related]
23. A Novel Self-Micro-Emulsifying Delivery System Enhances Enrichment of Eicosapentaenoic Acid and Docosahexaenoic Acid after Single and Repeated Dosing in Healthy Adults in a Randomized Trial.
West AL; Kindberg GM; Hustvedt SO; Calder PC
J Nutr; 2018 Nov; 148(11):1704-1715. PubMed ID: 30203029
[TBL] [Abstract][Full Text] [Related]
24. Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates.
Maki KC; Dicklin MR
Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):116-123. PubMed ID: 30550388
[TBL] [Abstract][Full Text] [Related]
25. [Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers].
Beckermann B; Beneke M; Seitz I
Arzneimittelforschung; 1990 Jun; 40(6):700-4. PubMed ID: 2144420
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of Single and Multiple Doses of Omega-3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open-Label Study.
Jing S; Zhang Z; Chen X; Miao R; Nilsson C; Lin Y
Clin Pharmacol Drug Dev; 2020 Nov; 9(8):985-994. PubMed ID: 32567203
[TBL] [Abstract][Full Text] [Related]
27. Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions.
Zuijdgeest-van Leeuwen SD; Dagnelie PC; Rietveld T; van den Berg JW; Wilson JH
Br J Nutr; 1999 Dec; 82(6):481-8. PubMed ID: 10690163
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of OM3-PL/FFA Pharmacokinetics After Single and Multiple Oral Doses in Healthy Volunteers.
Lapointe JF; Harvey L; Aziz S; Hegele RA; Lemieux P
Clin Ther; 2019 Dec; 41(12):2500-2516. PubMed ID: 31679821
[TBL] [Abstract][Full Text] [Related]
29. Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil.
Ramprasath VR; Eyal I; Zchut S; Shafat I; Jones PJ
Lipids Health Dis; 2015 Nov; 14():142. PubMed ID: 26537218
[TBL] [Abstract][Full Text] [Related]
30. [Separation of eicosapentaenoic acid ethyl ester and docosahexaenoic acid ethyl ester by simulated moving bed chromatography].
Dong Q; Li M; Yang Y; Bao Z; Yang Q; Zhang Z; Ren Q
Se Pu; 2018 Sep; 36(9):858-865. PubMed ID: 30251513
[TBL] [Abstract][Full Text] [Related]
31. Lipid structure does not modify incorporation of EPA and DHA into blood lipids in healthy adults: a randomised-controlled trial.
West AL; Burdge GC; Calder PC
Br J Nutr; 2016 Sep; 116(5):788-97. PubMed ID: 27424661
[TBL] [Abstract][Full Text] [Related]
32. Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study.
Guo XF; Tong WF; Ruan Y; Sinclair AJ; Li D
Prostaglandins Leukot Essent Fatty Acids; 2020 Jul; 158():102033. PubMed ID: 31740197
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial.
Köhler A; Sarkkinen E; Tapola N; Niskanen T; Bruheim I
Lipids Health Dis; 2015 Mar; 14():19. PubMed ID: 25884846
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of a phospholipid-enhanced fish oil versus krill oil product on plasma levels of eicosapentaenoic and docosahexaenoic acids after acute administration: A randomized, double-blind, crossover study.
Guarneiri LL; Wilcox ML; Maki KC
Nutrition; 2023 Oct; 114():112090. PubMed ID: 37413768
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.
Yang ZH; Amar M; Sampson M; Courville AB; Sorokin AV; Gordon SM; Aponte AM; Stagliano M; Playford MP; Fu YP; Yang S; Mehta NN; Remaley AT
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178279
[TBL] [Abstract][Full Text] [Related]
36. An experimental study on transcutaneous absorption of ethylesters of eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) in pigs.
Taugbøl O; Framstad T; Rest JR
Acta Vet Scand; 1996; 37(3):273-7. PubMed ID: 8996873
[TBL] [Abstract][Full Text] [Related]
37. Relative levels of dietary EPA and DHA impact gastric oxidation and essential fatty acid uptake.
Dasilva G; Boller M; Medina I; Storch J
J Nutr Biochem; 2018 May; 55():68-75. PubMed ID: 29413491
[TBL] [Abstract][Full Text] [Related]
38. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats.
Willumsen N; Vaagenes H; Lie O; Rustan AC; Berge RK
Lipids; 1996 Jun; 31(6):579-92. PubMed ID: 8784738
[TBL] [Abstract][Full Text] [Related]
39. Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart.
Murphy MG; Wright V; Ackman RG; Horackova M
Mol Cell Biochem; 1997 Dec; 177(1-2):257-69. PubMed ID: 9450671
[TBL] [Abstract][Full Text] [Related]
40. Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs.
Frøyland L; Vaagenes H; Asiedu DK; Garras A; Lie O; Berge RK
Lipids; 1996 Feb; 31(2):169-78. PubMed ID: 8835405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
